Acessibilidade / Reportar erro

Microwave-Assisted Synthesis of β-1,2,3-Triazolyl-α-amino Esters

Abstract

The reaction of ethyl (p-methoxyphenylimino)acetate with propargyl bromide mediated by activated zinc powder afforded alkynyl amine, which was then reacted with a variety of organic azides using a microwave energy source, leading to β-1,2,3-triazolyl-α-amino esters in good yield.

Keywords:
microwave; amino ester; click chemistry; addition reaction; 1,2,3-triazole


Introduction

Since the seminal discovery of Sharpless and co-workers1Kolb, H. C.; Finn, M. G.; Sharpless, K. B.; Angew. Chem. 2001, 113, 2056.,2Rostovtsev, V. V.; Green, L. G.; Fokin, V. V.; Sharpless, K. B.; Angew. Chem., Int. Ed. 2002, 41, 2596. and Meldal and co-workers3Tornøe, C. W.; Christensen, C.; Meldal, M.; J. Org. Chem. 2002, 67, 3057. on alkyne cycloaddition using copper salts, under mild conditions, to give 1,4-disubstituted 1,2,3-triazoles in high yields and rate acceleration, an immense number of papers have been published.

In 2001, Sharpless, Kolb and Finn1Kolb, H. C.; Finn, M. G.; Sharpless, K. B.; Angew. Chem. 2001, 113, 2056. of The Scripps Research Institute gave the name "Click chemistry" to the very best chemical reactions. The CuI catalyzed azide-alkyne cycloaddition (CuAAC) reaction4Worrell, B. T.; Malik, J. A.; Fokin, V. V.; Science 2013, 340, 457. is in fact a premier example of click chemistry that can easily fulfill the prerequisites for making covalent connections between two molecular building blocks in a facile and selective way, under mild reaction conditions with no or little by-products.5Finn, M. G.; Fokin, V. V.; Chem. Soc. Rev. 2010, 39, 1231. The azides, being a rare example of a 1,3-dipolar reagent, are not very reactive but are preferred due to their relative lack of side reactions and stability in typical synthetic conditions.

The versatility and range of the reaction has been demonstrated by its use in different areas of science such as materials, drug discovery,6Tron, G. C.; Pirali, T.; Billington, R. A.; Canonico, P. L.; Sorba, G.; Genazzani, A. A.; Med. Res. Rev. 2008, 28, 278. bioconjugation,7Dong, J.; Sharpless, K. B.; Kwisnek, L.; Oakdale, J. S.; Fokin, V. V.; Angew. Chem., Int. Ed. 2014, 53, 9466. polymers,8Lutz, J. F.; Borner, H. G.; Prog. Polym. Sci. 2008, 33, 1.supramolecular chemistry,9Golas, P. L.; Matyjaszewski, K.; QSAR Comb. Sci. 2007, 26, 1116; Marois, J. S.; Cantin, K.; Desmarais, A.; Morin, J. F.; Org. Lett. 2008, 10, 33. DNA labeling,1010 Lutz, J. F.; Schlaad, H.; Polymer 2008, 49, 817. synthesis of oligonucleotides,1111 Nuzzi, A.; Massi, A.; Dondoni, A.; QSAR Comb. Sci. 2007, 26, 1191. and the preparation of stationary phases for high performance liquid chromatography (HPLC) columns,1212 Guo, Z.; Lei, A.; Liang, X.; Xu, Q.; Chem. Commun. 2006, 4512. to name just some of the recent applications of this reaction.1313 Agalave, S. G.; Maujan, S. R.; Pore, V.; Chem. - Asian J. 2011, 6, 2696. It is noteworthy that the 1,2,3-triazole ring does not occur in nature.

Due to the relative resilience of 1,2,3-triazole species to metabolic degradation and their ability to form hydrogen bonds that can improve solubility,1414 Dalvie, D. K.; Kalgutkar, A. S.; Khojasteh-Bakht, S. C.; Obach, R. S.; Donnell, J. P. O.; Chem. Res. Toxicol. 2002, 15, 269.,1515 Horne, W. S.; Yadav, M. K.; Stout, C. D.; Ghadiri, M. R.; J. Am. Chem. Soc. 2004, 126, 15366. the importance of this heterocyclic ring is growing, especially focusing on drug discovery. Some examples of applications of the 1,2,3-triazole moiety in the field of medicinal chemistry as a pharmacophore have been shown, such as anticancer, HIV protease inhibitors, antituberculosis, antifungal, and antibacterial (Figure 1).1313 Agalave, S. G.; Maujan, S. R.; Pore, V.; Chem. - Asian J. 2011, 6, 2696.

Figure 1
Structures of biologically active 1,2,3-triazoles.

β-1,2,3-Triazolyl-α-amino esters are rarely described in the literature; in the previous syntheses described in the literature, three approaches were basically used. One of them used propargyl amino acids as building blocks,1616 Mindt, T. L.; Schibli, R.; J. Org. Chem. 2007, 72, 10247.,1717 Mindt, T. L.; Struthers, H.; Brans, L.; Anguelov, T.; Schweinsberg, C.; Maes, V.; Tourwé, D.; Schibli, R.; J. Am. Chem. Soc. 2006, 128, 15096. some of which are commercially available, and a second made use of azide amino esters as a precursor for the cycloaddition of the alkynes.1818 Stanley, N. J.; Pedersen, D. S.; Nielsen, B.; Kvist, T.; Mathiesen, J. M.; Brauner-Osborne, H.; Taylos, D. K.; Abell, A. D.; Bioorg. Med. Chem. Lett. 2010, 20, 7512.,1919 Ruan, Y.-B.; Yu, Y.; Li, C.; Bogliotti, N.; Tang, J.; Xie, J.; Tetrahedron 2013, 69, 4603. In both cases, β-1,2,3triazolyl-α-amino esters were afforded from low to high yields, despite the known complexation of nitrogen ligands with CuI ligands.2022 Dondoni, A.; Giovannini, P. P.; Massi, A.; Org. Lett. 2004, 17, 2929.,2121 Girard, C.; Onen, E.; Aufort, M.; Beauviè, S.; Samson, E.; Herscovici, J.; Org. Lett. 2006, 8, 1689. The third method was based on the reaction between a masked and protected azidofunctionalized glycine and an ethynyl glycine, affording disubstituted 1,2,3-triazole C-glycosyl amino esters.2222 Dondoni, A.; Giovannini, P. P.; Massi, A.; Org. Lett. 2004, 17, 2929.

Microwave irradiation as a non-conventional heating source has been shown to be of paramount importance as a tool with evident advantages when compared to traditional procedures: reduced reaction times, improved reaction yields, application in solvent-free conditions, and improving the product selectivity and chemical yield.2323 Kappe, C. O.; Dallinger, D.; Murphree, S. S.; Practical Microwave Synthesis for Organic Chemists; Wiley-VCH: Weinheim, 2009.

Results and Discussion

To synthesize β-1,2,3-triazolyl-α-amino esters, starting materials were assembled by reaction of propargyl bromide with imino ester in the presence of Zn metal (Scheme 1). Although the reaction conditions are known, we performed a short screen to try to improve the reaction conditions.

Scheme 1
Preparation of ethyl 2-(4-methoxyphenylamino)pent-4-ynoate (3).

We initially examined the reaction of propargyl bromide (4 mmol) and ethyl(p-methoxyphenylimino) acetate (5 mmol) mediated by Zn powder (6 mmol) under solvent free conditions2424 Zhang, Y.; Han, M.; J. Chem. Res. 2011, 35, 568. and found a trace amount of the product in our case. The same reaction was carried out in tetrahydrofuran (THF) at different temperatures and it was found that the reaction carried out at room temperature furnished 20% product, while at low temperatures, i.e., 0 ºC, this resulted in 36% of the targeted product. When the temperature was decreased to –20 ºC, we observed an increase in yield to 52%; however, a further decrease in temperature did not affect the reaction yield. The reaction failed to produce any isolable product when THF-H2O (1:1) was used as the solvent. After screening the reaction conditions, the optimal solvent for this propargylation was found to be dimethylformamide (DMF), which furnished compound 3 in 62% yield at –20 ºC within 20 min.

With the starting material in hand, we began the screen to search for the optimal reaction conditions to produce the 1,2,3-triazole ring via CuI-catalyzed Huisgen 1,3-dipolar cycloaddition reaction. For this purpose, we used benzyl azide and ethyl 2-(4-methoxyphenylamino)pent-4-ynoate as model reagents in the presence of various copper catalysts using microwaves (MW) as an energy source (Scheme 2).

Scheme 2
Synthesis of β-1,2,3-triazolyl-α-amino esters.

Only poor yield (5%) and traces (Table 1, entries 3 and 4) of the product were observed when using CuCN and Cu(OTf)2 as catalysts in the absence of a base, while CuSO4. 5H2O led to product in 51% yield and CuI furnished product in 53 % yield. Further attempts were made to optimize the solvent, we tried this reaction in aprotic solvent (MW-nonabsorbent), e.g., THF; protic solvent (MW-absorbing), e.g., MeOH; and neat conditions (Table 1, entries 2, 5 and 6, respectively). We found that reaction works with and without solvent though yield was poor. In order to increase yield of reaction pentamethyldiethylenetriamine (PMDTA) was used which showed 100% conversion of starting material to product. PMDTA is known to form a complex with copper iodide,2525 Stefani, H. A.; Vasconcelos, S. N. S.; Manarin, F.; Leal, D. M.; Souza, F. B.; Madureira, L. S.; Zukerman-Schpector, J.; Eberlin, M. N.; Godoi, M. N.; Galaverna, R. S.; Eur. J. Org. Chem. 2013, 18, 3780. but the isolated yield was not 100%. Following the addition of PMDTA, and employing CuI and THF as solvents, the yields increased within the range of 60 to 75% (Table 1, entries 9 and 7, 8, respectively). We have done a reaction in neat condition using PMDTA which furnished product in 64% yield but solid azides, e.g., sugar azides, didn't work in solvent free conditions so THF was found well suited for this reaction (Table 1, entry 7). This reaction was also carried out in oil bath at 100 ºC and after 3 h we obtained product in comparable yield (Table 1, entry 11).

Table 1
Optimized reaction conditions for the synthesis of β-1,2,3- triazolyl-α-amino esters

With the optimal conditions in hand, ethyl 2-(4-methoxyphenylamino)pent-4-ynoate (0.3 mmol), organic azide (0.4 mmol), PMDTA (1 eq), CuI (10 mol%), and THF (3.0 mL) were added to a microwave vial equipped with a magnetic stirring bar (Scheme 3). The sealed mixture was heated under microwave irradiation at 100 ºC for 5 min; the scope was then established and the CuI-catalyzed cycloaddition of terminal alkyne was subjected to a variety of organic azides. The results are summarized in Table 2.

Scheme 3
Synthesis of β-1,2,3-triazolyl-α-amino esters.
Table 2
Reactions of 3 with various aryl and alkyl azides

As is evident from the data in Table 2, the electron-donating and electron-withdrawing substituents in the aryl ring were well tolerated and gave good yields (Table 2, entries 2). A variety of functional groups, including methoxy, chloride, nitro and bromide, along with sugar-containing azides,2626 Bellomo, A.; Bertucci, A.; de la Sovera, V.; Carrau, G.; Raimondi, M.; Zacchino, S.; Stefani, H. A.; Gonzalez, D.; Lett. Drug Des. Discovery 2014, 11, 67.,2727 Carrau, G.; Drewes, C. C.; Shimada, A. L. B.; Bertucci, A.; Farsky, S. H. P.; Stefani, H. A.; Gonzalez, D.; Bioorg. Med. Chem. 2013, 21, 4225. were compatible with the reaction conditions; all gave triazolic products in good yields (Table 2, see entries 2-4 and 6-8).

Conclusions

We have demonstrated that non-natural β-1,2,3triazolyl-α-amino esters can be successfully obtained through a simple reaction from ethyl glyoxyl imines and preformed propargylzinc reagent, followed by the formation of 1,2,3-triazoles through click chemistry, in moderate to good yields. It was found that the microwave irradiation dramatically reduces the reaction times from hours to several minutes, which is an important factor on the viability of this synthetic method. In addition, the products are obtained in comparable yields with those obtained under conventional thermal conditions.

Thus, we found a reliable reaction system, which was able to provide an important variety of 1,2,3-triazolyl-αamino ester backbones in very useful reaction conditions. The extension of the process to cleavable amines, as well as the development of a chiral version are currently underway and will be reported in due course. The identities and purities of the products were confirmed by 1H and 13C nuclear magnetic resonance (NMR) spectroscopy and high-resolution mass spectrometry.

Experimental

Melting points were determined on a Büchi melting point apparatus and are provided uncorrected. MW assisted reactions were carried out in MW synthesis reactor monowave 300 Anton Paar. All compounds were characterized using 1H and 13C NMR spectroscopy as well as Fourier transform mass spectrometry (FTMS) with probe electrospray ionization (pESI). Copies of the 1H and 13C NMR spectra can be found in the Supplementary Information. The 1H and 13C NMR spectroscopic data were recorded with a 300 MHz instrument. The chemical shifts (d) for the 1H NMR experiments are reported in parts per million (ppm) and measured relative to the signals for tetramethylsilane (TMS) (d 0.00 ppm). The chemical shifts for the 13C NMR spectra are reported in ppm relative to deuterated chloroform (d 77.23 ppm), unless otherwise stated, and all data were recorded using 1H decoupling. Column chromatography was performed using silica gel (230-400 mesh). Thin-layer chromatography (TLC) was performed using silica gel UV 254, 0.20 mm thickness. For visualization, TLC plates were either placed under UV light, or stained with iodine or acidic vanillin solution. Solvents and reagents were of analytical grade or the highest grade commercially available and were used without further purification.

Synthesis of ethyl (p-methoxyphenylimino)acetate (1)

A mixture of ethyl (p-methoxyphenylimino)acetate (0.62 g, 5 mmol) and ethyl glyoxalate (0.51 g, 5 mmol) in 5 mL of THF was stirred at room temperature for 1 h. Then the corresponding mixture was concentrated under vacuum and used in the next step without any further purification. The product was obtained as a brown oil; infrared (IR) (film) νmax / cm-1 2985, 2941, 2845, 1737, 1643, 1596, 1246, 1032, 840; 1H NMR (300 MHz, CDCl3) δ 7.03 (s, 1H), 7.37 (d, 2H, J 9 Hz), 6.94 (d, 2H, J 9 Hz), 4.42 (q, 2H, J 7.2 Hz), 3.84 (s, 3H), 1.42 (t, 3H, J 7.1 Hz); 13C NMR (75 MHz, CDCl3) δ 173.0, 154.2. 151.9, 143.7, 115.8, 114.9, 54.1, 29.2, 14.0.

Procedure to activate zinc dust

Zinc powder (0.39 g, 6 mmol) was added into a flamedried round-bottom flask fitted with a magnetic bar and dropping funnel; the flask was flashed with dry nitrogen. The zinc powder was heated to 60-70 °C. 1,2-Dibromomethane (0.1 mL in 0.5 mL THF) was added dropwise, the temperature was maintained for 10 min and then the flask was cooled to room temperature. Trimethylchlorosilane (0.1 mL in 0.5 mL THF) was added, and the mixture was stirred at room temperature for 15 min. Solvent was evaporated from the activated zinc under reduced pressure.

Procedure for the preparation of ethyl 2-((4-methoxy) phenylamino)pent-4-ynoate (3)

In a dried round-bottom flask fitted with magnetic bar and dropping funnel, activated zinc powder (0.39 g, 6 mmol) and ethyl (p-methoxyphenylimino) acetate (0.83 g, 4 mmol) were added at 0 ºC. Propargyl bromide (0.60 g, 5 mmol) in 0.5 ml DMF was added dropwise over 5 min at 0 ºC and then stirred for 15 min at room temperature. After complete reaction, saturated aqueous ammonium chloride was poured into the mixture and stirred for 5 min. The reaction mixture was extracted with EtOAc (3 × 15 mL) and the combined organic layers were dried over anhydrous MgSO4; after filtration and solvent removal, the residue was purified by flash chromatography on silica gel (eluent consisting of hexane:EtOAc 9.5:0.5) to obtain oil product.

Ethyl 2-((4-methoxyphenyl)amino)pent-4-ynoate (3)

IR (film) νmax / cm-13368, 3286, 2985, 2940, 2836, 2121, 1734, 1542, 1514, 1033, 825; 1H NMR (300 MHz, CDCl3) δ 6.70 (d, 2H, J 8.9 Hz), 6.56 (d, 2H, J 8.9 Hz), 4.15-4.11 (m, 2H), 4.09-4.05(m, 1H), 3.64 (s, 3H), 2.66-2.64 (m, 2H), 2.01(s, 1H), 1.20 (t, 3H, J 7.1 Hz); 13C NMR (75 MHz, CDCl3) δ 172.2, 154.2, 141.7, 115.7, 114.9, 80.7, 72.3, 61.4, 55.6, 55.5, 22.9, 14.2; HRMS (FTMS + pESI) calcd. for C14H17NO3 [M]+: 247.1247; found: 247.1241.

General procedure for the synthesis of 1,2,3-triazole derivatives 5a-l

Ethyl 2-(4-methoxyphenylamino)pent-4-ynoate (0.3 mmol), organic azide (0.4 mmol), PMDTA (1 eq), CuI (10 mol%), and THF (3.0 mL) were added to a microwave vial equipped with a magnetic stirring bar. The sealed mixture was heated under microwave irradiation at 100 ºC for 5 min. The reaction mixture was cooled to ambient temperature. The reaction mixture was then poured into aq. NH4Cl and extracted with EtOAc (2 × 10 mL). The combined organic layers were dried over anhydrous magnesium sulfate and solvent was removed under reduced pressure and then the residue was purified by a flash column (hexane:ethyl acetate 4:6) to give the products as light-yellow oil. The identities and purities of the products were confirmed by TLC, 1H and 13C NMR spectroscopy and high-resolution mass spectrometry.

Ethyl 3-(1-benzyl-1H-1,2,3-triazol-4-yl)-2-(4-methoxyphenylamino)propanoate (5a)

Yield: 0.088 g (74%); brown solid; m.p. 84-85 ºC; IR (film) νmax / cm-1 3368, 3131, 2978, 2839, 1723, 1618, 1511, 1468, 1337, 1246, 1175, 1099, 1035, 709, 681; 1H NMR (300 MHz, CDCl3) δ 7.27-7.24 (m, 3H), 7.20 (s, 1H), 7.14-7.12 (m, 2H), 6.67 (d, 2H, J8.9 Hz), 6.50 (d, 2H, J 8.9 Hz), 5.39 (s, 2H), 4.20 (t, 1H, J 5.7 Hz), 4.04 (q, 2H, J 7.2 Hz), 3.64 (s, 3H), 3.20-3.04 (m, 2H), 1.09 (t, 3H, J 7.2 Hz); 13C NMR (75 MHz, CDCl3) δ 173.1, 152.9, 143.7, 140.6, 134.7, 129.0, 128.6, 127.9, 122.1, 115.4, 114.8, 61.2, 57.8, 55.7, 54.0, 29.2, 14.1; HRMS (FTMS + pESI) calcd. for C21H24N4O3 [M]+: 381.1899; found: 381.1891.

Ethyl 3-(1-(2-methoxyphenyl)-1H-1,2,3-triazol-4-yl)-2-(4-methoxyphenylamino)propanoate (5b)

Yield: 0.087 g (73%); white solid; m.p. 87-98 ºC; IR (film) νmax / cm-1 3363, 2982, 2836, 1732, 1603, 1510, 1467, 1441, 1372, 1236, 1179, 1125, 1099, 1035, 823, 756, 698, 672; 1H NMR (300 MHz, CDCl3) δ 7.96 (s, 1H), 6.78 (d, 1H, J 7.8 Hz), 7.44-7.39 (m, 1H), 7.13-7.06 (m, 2H), 6.79 (d, 2H, J 8.7 Hz), 6.70 (d, 2H, J 8.9 Hz), 4.40 (t, 1H, J 5.8 Hz), 4.22 (q, 2H, J 7.2 Hz), 3.86 (s, 3H), 3.74 (s, 3H), 3.43-3.32 (m, 2H), 1.24 (t, 3H, J 7.2 Hz); 13C NMR (75 MHz, CDCl3) δ 173.1, 153.0, 150.0, 142.5, 140.4, 129.9, 126.3, 125.3, 124.3, 121.2, 115.6, 114.8, 112.3, 61.2, 57.97, 55.91, 55.69, 29.13, 14.12; HRMS (FTMS + pESI) calcd. for C21H24N4O4 [M]+: 397.1877; found: 397.1850.

Ethyl 3-(1-(4-chlorophenyl)-1H-1,2,3-triazol-4-yl)-2-(4-methoxyphenylamino)propanoate (5c)

Yield: 0.086 g (72%); grey solid; m.p. 108-109 ºC; IR (film) νmax / cm-1 3311, 3140, 2987, 2834, 1727, 1618, 1512, 1502, 1469, 1338, 1246, 1236, 1179, 1032, 1039, 817, 830, 707, 683; 1H NMR (300 MHz, CDCl3) δ 7.66 (s, 1H), 7.64 (d, 2H, J 8.9 Hz), 7.50 (d, 2H, J 8.8 Hz), 6.79 (d, 2H, J 8.9 Hz), 6.66 (d, 2H, J 8.5 Hz), 4.37 (bs, 1H), 4.23 (q, 2H, J 7.2 Hz), 3.74 (s, 3H), 3.43-3.32 (m, 2H), 1.26 (t, 3H, J 7.2 Hz); 13C NMR (75 MHz, CDCl3) δ 173.0, 153.0, 144.3, 140.5, 135.5, 134.3, 129.8, 121.5, 120.3, 115.3, 114.9, 115.6, 114.8; 61.3, 57.6, 55.6, 29.1, 14.1; HRMS (FTMS + pESI) calcd. for C20H2135ClN4O3[M]+: 401.1380; found: 401.1347; HRMS (FTMS + pESI) calcd. for C20H2137ClN4O3[M]+: 403.1350; found: 403.1335.

Ethyl 2-(4-methoxyphenylamino)-3-(1-(3-nitrophenyl)-1H-1,2,3-triazol-4-yl)propanoate (5d)

Yield: 0.077 g (63%); orange solid; m.p. 154-155 ºC; IR (film) νmax / cm-1 3361, 3140, 2989, 2938, 2832, 1731, 1621, 1534, 1466, 1443, 1356, 1237, 1178, 1029, 826, 753; 1H NMR (300 MHz, CDCl3) δ 8.46 (s, 1H), 8.22 (d, 1H, J 8.1 Hz), 8.07 (d, 1H, J 8.1 Hz), 7.8 (s, 1H), 7.67 (t, 1H, J 8.1 Hz), 6.71 (d, 2H, J 9 Hz), 6.58 (d, 2H, J 9 Hz), 4.30 (t, 1H, J 5.6 Hz), 4.16 (q, 2H, J 7.2 Hz), 3.65 (s, 3H), 3.37-3.18 (m, 2H), 1.19 (t, 3H, J 7.2 Hz); 13C NMR (75 MHz, CDCl3) δ 172.8, 153.2, 144.8, 140.2, 137.7, 130.9, 125.8, 123.0, 120.4, 115.6, 100.0, 61.5, 57.6, 55.7, 29.1, 14.1; HRMS (FTMS + pESI) calcd. for C20H21N5O5 [M]+: 412.1621; found: 412.1591.

Ethyl 3-(1-decyl-1 H-1,2,3-triazol-4-yl)-2-(4-methoxyphenylamino)propanoate (5e)

Yield: 0.096 g (70%); brown solid; m.p. 58-59 ºC; IR (film) νmax / cm-1 3321, 3141, 2958, 2939, 2831, 1732, 1609, 1511, 1463, 1373, 1214, 1056, 839, 701, 683; 1H NMR (300 MHz, CDCl3) δ 7.27 (s, 1H), 6.68 (d, 1H, J 8.8 Hz), 6.52 (d, 2H, J 8.9 Hz), 4.40 (m, 3H), 4.10 (q, 2H, J 7.2 Hz), 3.64 (s, 3H), 3.23-3.05 (m, 2H), 1.79 (t, 3H, J 6.7 Hz), 1.20-1.09 (m, 2H), 0.82 (t, 3H, J 6.4 Hz); 13C NMR (75 MHz, CDCl3) δ 173.1, 152.8, 140.6, 121.9, 115.3, 114.8, 61.1, 57.8, 55.6, 50.2, 31.85, 30.2, 29.5, 29.4, 29.3, 28.9, 22.6, 14.1, 14.0; HRMS (FTMS + pESI) calcd. for C26H42N4O3 [M]+: 459.3336; found: 459.3313.

Ethyl 3-(1-(3-chlorophenyl)-1H-1,2,3-triazol-4-yl)-2-(4-methoxyphenylamino)propanoate (5f)

Yield: 0.085 g (71%); brown solid; m.p. 134-135 ºC. IR (film) νmax / cm-13317, 3140, 3012, 2834, 1726, 1620, 1512, 1503, 1469, 1338, 1247, 1238, 1171, 1032, 1032, 815, 708, 681; 1H NMR (300 MHz, CDCl3) δ 7.74 (s, 1H), 7.63-7.62 (m, 1H), 7.49-7.46 (m, 1H), 7.34-7.28 (m, 2H), 6.67 (d, 2H, J 9 Hz), 6.54 (d, 2H, J 9 Hz), 4.29 (t, 1H, J 5.5 Hz), 4.12 (q, 2H, J 7.2 Hz), 3.62 (s, 3H), 3.31-3.13 (m, 2H), 1.14 (t, 3H, J 7.2 Hz); 13C NMR (75 MHz, CDCl3) δ 173.0, 152.0, 144.3, 140.5, 137.8, 135.4, 130.7, 128.6, 120.5, 120.4, 118.3, 115.4, 114.9, 61.3, 57.6, 55.6, 29.1, 14.1; HRMS (FTMS + pESI) calcd. for C20H2135ClN4O3[M]+: 401.1380; found: 401.1350; HRMS (FTMS + pESI) calcd. for C20H2137ClN4O3[M]+: 403.1350; found: 403.1336.

Ethyl 2-(4-methoxyphenylamino)-3-(1-(2-nitrophenyl)-1H-1,2,3-triazol-4-yl)propanoate (5g)

Yield: 0.075 g (61%); brown oil; IR (film) νmax / cm-13361, 3139, 2976, 2935, 2825, 1732, 1617, 1532, 1461, 1353, 1231, 1162, 1020, 826, 753, 702, 689; 1H NMR (300 MHz, CDCl3) δ 7.99 (d, 1H, J 8.1 Hz), 6.71-7.75 (m, 3H), 7.50 (d, 1H, J 7.5 Hz), 6.67 (d, 2H, J 8.7 Hz), 6.57 (d, 2H, J 8.7 Hz), 4.31 (t, 1H, J 5.7 Hz), 4.15 (q, 2H, J 7.2 Hz), 3.05 (s, 3H), 3.35-3.17 (m, 2H), 1.18 (t, 3H, J 7.2 Hz); 13C NMR (75 MHz, CDCl3) δ 172.9, 153.0, 143.9, 140.5, 133.7, 130.6, 130.3, 127.9, 125.5, 123.8, 115.5, 114.9, 61.4, 57.6, 55.7, 29.1, 14.1; HRMS (FTMS + pESI) calcd. for C20H21N5O5[M]+: 412.1621; found: 412.1576.

Ethyl 3-(1-(4-bromophenyl)-1H-1,2,3-triazol-4-yl)-2-(4-methoxyphenylamino)propanoate (5h)

Yield: 0.104 g (78%); white solid; m.p. 128-129 ºC; IR (film) νmax / cm-13319, 3142, 2958, 2823, 1726, 1620, 1512, 1498, 1466, 1246, 1238, 1199, 1173, 1052, 817, 707, 678; 1H NMR (300 MHz, CDCl3) δ 7.81 (s, 1H), 7.64-7.55 (m, 4H), 6.78 (d, 1H, J 8.7 Hz), 6.79 (d, 2H, J 8.7 Hz), 6.68 (d, 2H, J 8.9 Hz), 4.38 (t, 1H, J 5.7 Hz), 4.22 (s, NH), 4.17 (q, 2H, J 7.2 Hz), 3.73 (s, 3H), 3.41-3.23 (m, 2H), 1.29 (t, 3H, J 7.2 Hz); 13C NMR (75 MHz, CDCl3) δ 173.0, 152.9, 144.3, 140.5, 135.9, 132.8, 122.1, 120.3, 115.4, 114.9, 61.3, 57.5, 55.6, 29.1, 14.1; HRMS (FTMS + pESI) calcd. for C20H2179BrN4O3[M]+: 445.0875; found: 445.0864; HRMS (FTMS + pESI) calcd. for C20H2181BrN4O3[M]+: 447.0854; found: 447.0831.

Ethyl 3-(1-hexyl-1H-1,2,3-triazol-4-yl)-2-(4-methoxyphenolamino)propanoate (5i)

Yield: 0.083 g (74%); brown oil; IR (film) νmax / cm-13319, 3128, 2953, 2821, 1722, 1602, 1509, 1461, 1371, 1209, 1238, 1172, 1032, 815, 708, 681; 1H NMR (300 MHz, CDCl3) δ 7.26 (s, 1H), 6.69 (d, 1H, J 9 Hz), 6.52 (d, 2H, J 9 Hz), 4.23 (m, 3H), 4.11 (q, 2H, J 7.2 Hz), 3.65 (s, 3H), 3.24-3.06 (m, 2H), 1.80-1.75 (m, 2H), 1.22 (bs, 6H), 1.15 (t, 3H, J 7.2 Hz), 0.82 (t, 3H, J 5.7 Hz); 13C NMR (75 MHz, CDCl3) δ 173.2, 152.8, 143.1, 140.7, 121.9, 115.3, 114.8, 61.1, 57.7, 55.6, 50.2, 31.0, 30.2, 29.2, 26.0, 22.3, 14.1, 13.8; HRMS (FTMS + pESI) calcd. for C20H30N4O3 [M]+: 375.2397; found: 375.2359.

Ethyl 2-(4-methoxyphenylamino)-3-(1-phenyl-1H-1,2,3-triazol-4-yl)propanoate (5j)

Yield: 0.082 g (75%); white solid; m.p. 146-147 ºC; IR (film) νmax / cm-13317, 3146, 3089, 2989, 2840, 1721, 1614, 1511, 1461, 1380, 1241, 1210, 1090, 752, 710; 1H NMR (300 MHz, CDCl3) δ 7.78 (s, 1H), 7.60-7.57 (m, 2H), 7.42-7.28 (m, 3H), 6.68 (d, 2H, J 8.9 Hz), 6.55 (d, 2H, J 9 Hz), 4.29 (t, 1H, J 5.7 Hz), 4.12 (q, 2H, J 7.2 Hz), 3.62 (s, 3H), 3.31-3.14 (m, 2H), 1.44 (t, 3H, J 7.2 Hz); 13C NMR (75 MHz, CDCl3) δ 173.1, 152.9, 144.0, 140.6, 137.0, 129.7, 128.6, 120.4, 115.4, 114.9, 61.3, 57.6, 55.6, 29.2, 14.1; HRMS (FTMS + PESI) calcd. for C20H22N4O3 [M]+: 367.1771; found: 367.1731.

Ethyl 3-(1-((3aR,4S,7aR)-7-bromo-4-hydroxy-2,2-dimethyl-3a,4,5,7a-tetrahydro[1,3]benzodioxol-5-yl)-1H-1,2,3-triazol-4-yl)-2-(4-methoxyphenylamino)propanoate (5k)

Yield: 0.117 g (73%); brown gummy solid; IR (film) νmax / cm-13400-3000, 3317, 3297, 2983, 2931, 2821, 1722, 1602, 1623, 1467, 1316, 1234, 1084, 1057, 823; 1H NMR (300 MHz, CDCl3) δ 7.69 (s, 1H), 6.63 (d, 2H, J 9 Hz), 6.52 (d, 2H, J 9 Hz), 6.15-6.12 (m, 1H), 4.95-4.91 (m, 1H), 4.72-4.69 (m, 1H), 4.22-4.15 (m, 2H), 4.04 (q, 2H, J 7.2 Hz), 3.87-3.81 (m, 1H), 3.57 (s, 3H), 3.15-2.99 (m, 2H), 1.37 (s, 3H), 1.28 (s, 3H), 1.08 (t, 3H, J 7.2 Hz); 13C NMR (75 MHz, CDCl3) δ 174.9, 154.2, 144.5, 142.4, 131.2, 125.0, 122.8, 116.5, 115.8, 111.9, 79.3, 78.4, 72.5, 64.3, 62.2, 59.1, 56.2, 29.8, 28.4, 26.1, 14.5; HRMS (FTMS + pESI) calcd. for C23H2979BrN4O6[M]+: 537.1349; found: 537.1347; HRMS (FTMS + pESI) calcd. for C23H2981BrN4O6[M]+: 539.1328; found: 539.1315.

Ethyl 3-(1-((3aR,4S,7aR)-7-bromo-4-hydroxy-2,2-dimethyl-3a,4,5,7a-tetrahydro[1,3]benzodioxol-5-yl)-1H-1,2,3-triazol-4-yl)-2-(4-methoxyphenylamino)propanoate (5l)

Yield: 0.116 g (72%); brown gummy solid; IR (film) νmax / cm-13400-3000, 3319, 3296, 2982, 2931, 2823, 1723, 1604, 1621, 1467, 1318, 1235, 1083, 1056, 821; 1H NMR (300 MHz, CDCl3) δ 7.82 (s, 1H), 6.76-6.61 (m, 4H) 6.20 -6.15 (m, 1H), 5.47-5.45 (m, 1H), 4.73-4.71 (m, 1H), 4.47-4.43 (m, 2H), 4.37-4.30 (m, 2H), 4.17 (q, 2H, J 7.2 Hz), 3.71 (s, 3H), 3.28-3.17 (m, 2H), 1.45 (s, 3H), 1.42 (s, 3H), 1.22 (t, 3H, J 7.2 Hz); 13C NMR (75 MHz, CDCl3) δ 175.0, 154.3, 144.5, 142.4, 127.3, 126.9, 125.2, 116.7, 116.5, 115.8, 111.6, 78.0, 77.4, 69.7, 62.3, 60.9, 59.2, 56.2, 29.9, 28.0, 26.6, 14.5; HRMS (FTMS + pESI) calcd. for C23H2979BrN4O6[M]+: 537.1349; found: 537.1338; HRMS (FTMS + pESI) calcd. for C23H2981BrN4O6[M]+: 539.1328; found: 539.1323.

  • FAPESP has sponsored the publication of this article.
  • Supplementary Information
    Supplementary information (experimental details and analytical data for all new compounds, as well as the copies of 1H and 13C NMR spectra) is available free of charge at http://jbcs.sbq.org.br as PDF file.

Acknowledgments

The authors gratefully acknowledge the financial support provided by the São Paulo Research Foundation (FAPESP grant 2012/00424-2 and fellowship to A. N. K. 2012/20483-3) and the National Council for Scientific and Technological Development (CNPq fellowship 308.320/2010-7 to H. A. S.).

References

  • 1
    Kolb, H. C.; Finn, M. G.; Sharpless, K. B.; Angew. Chem 2001, 113, 2056.
  • 2
    Rostovtsev, V. V.; Green, L. G.; Fokin, V. V.; Sharpless, K. B.; Angew. Chem., Int. Ed. 2002, 41, 2596.
  • 3
    Tornøe, C. W.; Christensen, C.; Meldal, M.; J. Org. Chem 2002, 67, 3057.
  • 4
    Worrell, B. T.; Malik, J. A.; Fokin, V. V.; Science 2013, 340, 457.
  • 5
    Finn, M. G.; Fokin, V. V.; Chem. Soc. Rev 2010, 39, 1231.
  • 6
    Tron, G. C.; Pirali, T.; Billington, R. A.; Canonico, P. L.; Sorba, G.; Genazzani, A. A.; Med. Res. Rev. 2008, 28, 278.
  • 7
    Dong, J.; Sharpless, K. B.; Kwisnek, L.; Oakdale, J. S.; Fokin, V. V.; Angew. Chem., Int. Ed. 2014, 53, 9466.
  • 8
    Lutz, J. F.; Borner, H. G.; Prog. Polym. Sci. 2008, 33, 1.
  • 9
    Golas, P. L.; Matyjaszewski, K.; QSAR Comb. Sci. 2007, 26, 1116; Marois, J. S.; Cantin, K.; Desmarais, A.; Morin, J. F.; Org. Lett. 2008, 10, 33.
  • 10
    Lutz, J. F.; Schlaad, H.; Polymer 2008, 49, 817.
  • 11
    Nuzzi, A.; Massi, A.; Dondoni, A.; QSAR Comb. Sci. 2007, 26, 1191.
  • 12
    Guo, Z.; Lei, A.; Liang, X.; Xu, Q.; Chem. Commun. 2006, 4512.
  • 13
    Agalave, S. G.; Maujan, S. R.; Pore, V.; Chem. - Asian J 2011, 6, 2696.
  • 14
    Dalvie, D. K.; Kalgutkar, A. S.; Khojasteh-Bakht, S. C.; Obach, R. S.; Donnell, J. P. O.; Chem. Res. Toxicol 2002, 15, 269.
  • 15
    Horne, W. S.; Yadav, M. K.; Stout, C. D.; Ghadiri, M. R.; J. Am. Chem. Soc 2004, 126, 15366.
  • 16
    Mindt, T. L.; Schibli, R.; J. Org. Chem 2007, 72, 10247.
  • 17
    Mindt, T. L.; Struthers, H.; Brans, L.; Anguelov, T.; Schweinsberg, C.; Maes, V.; Tourwé, D.; Schibli, R.; J. Am. Chem. Soc. 2006, 128, 15096.
  • 18
    Stanley, N. J.; Pedersen, D. S.; Nielsen, B.; Kvist, T.; Mathiesen, J. M.; Brauner-Osborne, H.; Taylos, D. K.; Abell, A. D.; Bioorg. Med. Chem. Lett 2010, 20, 7512.
  • 19
    Ruan, Y.-B.; Yu, Y.; Li, C.; Bogliotti, N.; Tang, J.; Xie, J.; Tetrahedron 2013, 69, 4603.
  • 20
    Chan, T. R.; Hilgraf, R.; Sharpless, K. B.; Fokin, V. V.; Org. Lett 2004, 6, 2853.
  • 21
    Girard, C.; Onen, E.; Aufort, M.; Beauviè, S.; Samson, E.; Herscovici, J.; Org. Lett 2006, 8, 1689.
  • 22
    Dondoni, A.; Giovannini, P. P.; Massi, A.; Org. Lett. 2004, 17, 2929.
  • 23
    Kappe, C. O.; Dallinger, D.; Murphree, S. S.; Practical Microwave Synthesis for Organic Chemists; Wiley-VCH: Weinheim, 2009.
  • 24
    Zhang, Y.; Han, M.; J. Chem. Res. 2011, 35, 568.
  • 25
    Stefani, H. A.; Vasconcelos, S. N. S.; Manarin, F.; Leal, D. M.; Souza, F. B.; Madureira, L. S.; Zukerman-Schpector, J.; Eberlin, M. N.; Godoi, M. N.; Galaverna, R. S.; Eur. J. Org. Chem. 2013, 18, 3780.
  • 26
    Bellomo, A.; Bertucci, A.; de la Sovera, V.; Carrau, G.; Raimondi, M.; Zacchino, S.; Stefani, H. A.; Gonzalez, D.; Lett. Drug Des. Discovery 2014, 11, 67.
  • 27
    Carrau, G.; Drewes, C. C.; Shimada, A. L. B.; Bertucci, A.; Farsky, S. H. P.; Stefani, H. A.; Gonzalez, D.; Bioorg. Med. Chem. 2013, 21, 4225.

Data availability

Publication Dates

  • Publication in this collection
    July 2015

History

  • Received
    16 Jan 2015
  • Accepted
    08 May 2015
Sociedade Brasileira de Química Instituto de Química - UNICAMP, Caixa Postal 6154, 13083-970 Campinas SP - Brazil, Tel./FAX.: +55 19 3521-3151 - São Paulo - SP - Brazil
E-mail: office@jbcs.sbq.org.br